Your browser doesn't support javascript.
loading
[Vasoactive intestinal peptide (VIP) in the Verner-Morrison syndrome (author's transl)]. / Le peptide intestinal vasoactif (VIP) au cours du syndrome de Verner-Morrison.
Nouv Presse Med ; 8(18): 1505-8, 1979 Apr 21.
Article em Fr | MEDLINE | ID: mdl-224378
ABSTRACT
An early diagnosis of the Verner-Morrison syndrome will greatly enhance the chances of curative resection. There is a striking need for a simple diagnostic test. A number of suggestions have been made for the presumed hormone mediator of this syndrome. Numerous reports have led to a wide acceptance that vasoactive intestinal peptide (VIP) is the responsible mediator for the pharmacologic actions of this peptide are similar to the physiological characteristics noted in the watery diarrhea syndrome. A raised plasma VIP concentration, on the other hand, would suggest the presence of a tumour. These observations argue for the radioimmunoassay measurement of plasma VIP in a patient with the watery diarrhea syndrome.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeo Intestinal Vasoativo / Diarreia / Hormônios Gastrointestinais / Hipopotassemia Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Humans Idioma: Fr Revista: Nouv Presse Med Ano de publicação: 1979 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeo Intestinal Vasoativo / Diarreia / Hormônios Gastrointestinais / Hipopotassemia Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Humans Idioma: Fr Revista: Nouv Presse Med Ano de publicação: 1979 Tipo de documento: Article